DXR - NASDAQ

Daxor Corporation

DXR·NASDAQ

$11.09

+3.3%

HealthcareMedical - Instruments & Supplies

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$55.86M

EPS1.8400

P/E Ratio6.03

Earnings Date08/20/2026

dxr

Net Income

Last Annual Value

9.17M

3-Year CAGR

21%

5-Year CAGR

49%

10-Year CAGR

12%

Adjust for Inflation

Daxor Corporation Competitors Analysis of Net Income

DXR · NASDAQ

Company	Net Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
Daxor Corporation NASDAQ:DXR	9.17M	219.7%	14.1%	20.2%
Adicet Bio, Inc. NASDAQ:ACET	-116.80M	N/A	N/A	N/A
MiNK Therapeutics, Inc. NASDAQ:INKT	-12.49M	N/A	N/A	N/A
Spectral AI, Inc. NASDAQ:MDAI	-7.57M	N/A	N/A	N/A
Outlook Therapeutics, Inc. NASDAQ:OTLK	-62424.86B	N/A	N/A	N/A
Pulmonx Corporation NASDAQ:LUNG	-54.00M	N/A	N/A	N/A
Relmada Therapeutics, Inc. NASDAQ:RLMD	-57.39M	N/A	N/A	N/A
CervoMed Inc. NASDAQ:CRVO	-16.29M	N/A	N/A	N/A
Great Elm Group, Inc. NASDAQ:GEG	12.89M	-22.5%	N/A	3.2%
XBiotech Inc. NASDAQ:XBIT	-45.54M	N/A	N/A	N/A
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	-28.62M	N/A	N/A	N/A

Daxor Corporation Fair Value Envelope

DXR · NASDAQ

Our analysis suggests that DXR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.0866, this represents a potential HIDDEN relative to our calculated worth for Daxor Corporation.

HIDDEN

Intrinsic Value

Current Price: $11.0866

Related Guides

Blog Categories

Continue your DXR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.